|
Apr 17
|
Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025
|
|
Apr 17
|
Here's How You Should Play JNJ Stock After Q1 Earnings Beat
|
|
Apr 17
|
Netflix stock has been nearly unscathed by Trump tariffs. Some think it could be Silicon Valley’s version of Johnson & Johnson
|
|
Apr 17
|
This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row
|
|
Apr 16
|
Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ
|
|
Apr 16
|
J&J’s electrophysiology sales dip amid slow Varipulse start
|
|
Apr 16
|
Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz
|
|
Apr 16
|
Needham upgrades Boston Scientific on easing competition, growth opportunities
|
|
Apr 16
|
Is Johnson & Johnson (JNJ) the Best Dividend Monarch to Invest in Now?
|
|
Apr 16
|
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike
|
|
Apr 16
|
Jim Cramer: Johnson & Johnson (JNJ) Is a “Great American Company with a AAA Balance Sheet”
|
|
Apr 16
|
Johnson & Johnson (JNJ) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid STELARA ...
|
|
Apr 16
|
Q1 2025 Johnson & Johnson Earnings Call
|
|
Apr 15
|
Stocks fizzle after two-day rally driven by bank earnings and tech
|
|
Apr 15
|
These Stocks Moved the Most Today: Bank of America, Citigroup, Netflix, Boeing, Tesla, HPE, Applied Digital, and More
|
|
Apr 15
|
J&J expects a $400M hit from tariffs, mostly from China
|
|
Apr 15
|
J&J Forecasts $400 Million in Tariff-Related Costs This Year
|
|
Apr 15
|
Johnson & Johnson (JNJ): Stuck in a Range but Ready to Break Out if Legal Clouds Clear – Jim Cramer Weighs In
|
|
Apr 15
|
J&J projects $400m tariff hit but raises sales outlook
|
|
Apr 15
|
Equities Little Changed Intraday After Corporate Earnings
|